The COL1A1 Gene Ehlers-Danlos Syndrome Type 7A Genetic Test is a specialized diagnostic tool designed to identify mutations in the COL1A1 gene, which are associated with Ehlers-Danlos Syndrome Type 7A (EDS Type 7A). This condition is a rare variant of the Ehlers-Danlos Syndromes, a group of genetic disorders that affect the connective tissues supporting the skin, bones, blood vessels, and many other organs and tissues. Mutations in the COL1A1 gene can lead to defects in the production of type I collagen, a critical component of connective tissues, resulting in symptoms such as hypermobility of joints, skin hyperextensibility, and tissue fragility.
The test, priced at 4400 AED, is conducted at DNA Labs UAE, a state-of-the-art facility known for its comprehensive genetic testing services. Through a simple blood sample or other tissue samples, DNA Labs UAE can accurately analyze the COL1A1 gene for any mutations. The results from this test can provide crucial information for the diagnosis, treatment planning, and management of Ehlers-Danlos Syndrome Type 7A, helping affected individuals and their families understand their condition better and make informed health decisions.
The COL1A2 gene Ehlers-Danlos Syndrome Type 7B genetic test is a specialized diagnostic tool designed to identify mutations in the COL1A2 gene, which are associated with Ehlers-Danlos Syndrome Type 7B (EDS Type 7B). This specific type of Ehlers-Danlos Syndrome is characterized by hypermobility of the joints, skin hyperelasticity, and a propensity for bruising and scars. The COL1A2 gene plays a crucial role in the production of type I collagen, an essential component of the connective tissues throughout the body. Mutations in this gene can lead to the symptoms associated with EDS Type 7B.
Conducted at DNA Labs UAE, a leading facility in genetic testing, the test is aimed at individuals who exhibit symptoms of EDS Type 7B or have a family history of the condition, providing them with crucial information regarding their genetic status. The test involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed for specific mutations in the COL1A2 gene.
The cost of the COL1A2 gene Ehlers-Danlos Syndrome Type 7B genetic test at DNA Labs UAE is 4400 AED. This price reflects the comprehensive nature of the test, including the collection of the sample, the genetic analysis, and the provision of a detailed report on the findings. The results from this test can guide individuals and their healthcare providers in managing the condition, including making informed decisions about treatment and preventive measures.
The ADAMTS2 Gene Ehlers-Danlos Syndrome Type 7C Genetic Test is a specific diagnostic assessment available at DNA Labs UAE, designed to identify mutations in the ADAMTS2 gene, which are associated with Ehlers-Danlos Syndrome Type 7C (EDS Type 7C). EDS Type 7C, also known as dermatosparaxis, is a rare genetic disorder characterized by extremely fragile and saggy skin, easy bruising, and joint hypermobility, among other symptoms. This condition is inherited in an autosomal recessive pattern, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected.
The test is particularly crucial for individuals showing symptoms of EDS Type 7C, those with a family history of the condition, or potential carriers of the genetic mutation. Early diagnosis through this genetic test can lead to better management of the symptoms and a comprehensive understanding of the condition's implications for the patient and their family.
Conducted at DNA Labs UAE, a facility renowned for its advanced genetic testing capabilities, the test involves collecting a DNA sample, usually through a blood draw or a cheek swab. The laboratory then analyzes the ADAMTS2 gene for specific mutations that cause the condition.
The cost of the ADAMTS2 Gene Ehlers-Danlos Syndrome Type 7C Genetic Test at DNA Labs UAE is set at 4400 AED. While the price might seem significant, the value of obtaining a precise diagnosis cannot be overstated, as it opens the door to targeted interventions, genetic counseling, and the possibility of connecting with a community of individuals and families facing similar challenges.
The PYCR1 Gene Cutis Laxa Type 2B Autosomal Recessive Genetic Test is a specialized diagnostic assessment designed to identify mutations in the PYCR1 gene, which are linked to Cutis Laxa Type 2B, an autosomal recessive genetic disorder. This condition is characterized by a range of symptoms including loose, sagging skin, growth delays, and, in some cases, neurological and developmental issues. The test involves analyzing the patient's DNA to detect any genetic abnormalities in the PYCR1 gene that might indicate the presence of this condition.
Offered at DNA Labs UAE, the test is a critical tool for early detection and management of Cutis Laxa Type 2B, enabling healthcare providers to devise appropriate treatment and care plans for affected individuals. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify mutations in the PYCR1 gene. Through this genetic testing, families can gain valuable insights into their genetic makeup, allowing for informed decisions regarding health and family planning.
The ALDH18A1 gene plays a crucial role in the biosynthesis of proline, an amino acid important for the proper structure and function of proteins. Mutations in this gene can lead to Cutis Laxa Type 3A, a rare genetic disorder characterized by loose, sagging skin and a variety of systemic symptoms including joint laxity, developmental delays, and, in some cases, neurological issues. This autosomal recessive condition means that an individual must inherit two copies of the mutated gene, one from each parent, to be affected.
DNA Labs UAE offers a specialized genetic test to identify mutations in the ALDH18A1 gene, aiding in the diagnosis of Cutis Laxa Type 3A. This test is crucial for families seeking answers to unexplained symptoms related to skin elasticity and systemic involvement that may suggest this rare condition. The test cost is set at 4400 AED, reflecting the comprehensive analysis and the specialized expertise required to interpret the results accurately.
Undergoing this test can be an important step for affected individuals and their families to understand the genetic underpinnings of their condition, paving the way for tailored management and support strategies.
The PYCR1 gene Cutis Laxa Type 3B Autosomal Recessive Genetic Test is a specialized diagnostic procedure designed to identify mutations in the PYCR1 gene, which are responsible for Cutis Laxa Type 3B, a rare autosomal recessive disorder. This condition is characterized by loose, sagging skin and, in some cases, can also affect connective tissues throughout the body, leading to systemic complications. The test aims to provide definitive genetic evidence of the disorder, enabling accurate diagnosis, informed genetic counseling, and personalized management plans for affected individuals.
Performed at DNA Labs UAE, a leading facility in genetic testing, the test leverages advanced molecular techniques to analyze the PYCR1 gene for specific mutations. The process involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then meticulously examined for the presence of genetic anomalies associated with Cutis Laxa Type 3B.
The cost of the PYCR1 gene Cutis Laxa Type 3B Autosomal Recessive Genetic Test is set at 4400 AED. This price reflects the comprehensive nature of the test, from the initial collection of the sample to the detailed genetic analysis and reporting. Individuals undergoing this test at DNA Labs UAE can expect a high level of accuracy, confidentiality, and support throughout the testing process, ensuring they receive the critical information needed to address this genetic condition effectively.
The ELN Gene Cutis Laxa Autosomal Dominant Genetic Test is a specialized diagnostic tool designed to identify mutations in the ELN gene, which are associated with Cutis Laxa, a rare genetic disorder. This condition is characterized by the skin becoming inelastic and hanging loosely in folds, among other systemic manifestations that can affect the lungs, arteries, and skin. In its autosomal dominant form, only one copy of the mutated gene is necessary for a person to be affected, meaning it can be passed from an affected parent to their child.
The test, which costs 4400 AED, is conducted by DNA Labs UAE, a facility known for its advanced genetic testing capabilities. Through a simple sample of blood or saliva, the laboratory's state-of-the-art technology analyzes the ELN gene for any abnormalities or mutations that might indicate the presence of Cutis Laxa. This test is crucial for early diagnosis, which can significantly impact the management and treatment of the condition, helping to improve the quality of life for those affected. It also provides essential information for families regarding genetic counseling and the risk of passing the condition to future generations.
The COL2A1 Gene Czech Dysplasia Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the COL2A1 gene, which are indicative of Czech dysplasia. Czech dysplasia is a rare genetic disorder characterized by early-onset osteoarthritis, short stature, and other skeletal abnormalities. The COL2A1 gene plays a crucial role in the production of type II collagen, a major structural protein in cartilage and the vitreous humor of the eye. Mutations in this gene can disrupt the normal formation of these tissues, leading to the symptoms associated with Czech dysplasia.
The test, priced at 4400 AED, involves collecting a DNA sample from the patient, usually through a blood draw or cheek swab. This sample is then analyzed in the state-of-the-art facilities at DNA Labs UAE, employing advanced genetic sequencing techniques to detect any mutations in the COL2A1 gene. The results from this test can provide valuable information for the diagnosis, treatment planning, and genetic counseling for individuals and families affected by Czech dysplasia. It is a critical step in understanding the genetic basis of the condition and managing its symptoms effectively.
The DSPP Gene Dentin Dysplasia Type 2 Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the DSPP gene, which are responsible for Dentin Dysplasia Type 2. This condition affects the development of dentin, a hard tissue that forms the bulk of teeth beneath the enamel, leading to structural dental abnormalities. The test, priced at 4400 AED, involves collecting a DNA sample from the patient, usually through a blood draw or a cheek swab, and analyzing it for specific genetic mutations in the DSPP gene. Accurate diagnosis through this genetic testing can aid in understanding the condition better, allowing for tailored dental care and management strategies for affected individuals.
The DSPP Gene Dentinogenesis Imperfecta Shields Type 2 Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the DSPP gene which are responsible for Dentinogenesis Imperfecta (DI) Type 2. Dentinogenesis Imperfecta is a rare genetic disorder affecting dental development, leading to discolored, weak, or misshapen teeth. Specifically, Shields Type 2 DI is characterized by its manifestation alongside osteogenesis imperfecta, a condition affecting bone density and strength. The test, priced at 4400 AED, involves analyzing the patient's DNA to detect any abnormalities in the DSPP gene, thereby confirming the diagnosis and facilitating appropriate treatment planning. This genetic testing is crucial for early intervention and managing the dental and skeletal manifestations of the disorder effectively.
